Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study

Genes Chromosomes and Cancer

Volumn 25, Issue 3, 1999, Pages 212-221

  Laake, Kirsten ^a   Launonen, Virpi ^b   Niederacher, Dieter ^c   Gudlaugsdottir, Sigfridur ^d   Seitz, Susanne ^e   Rio, Pascale ^f   Champème, Marie Hélène ^g   Bièche, Ivan ^g   Birnbaum, Daniel ^h   White, Gavin ⁱ   Sztan, Marianna ^j   Sever, Natasa ^k   Plummer, Sarah ^l   Osorio, Ana ^m   Broeks, Annegien ⁿ   Huusko, Pia ^b   Spurr, Nigel ^o   Borg, Åke ^p   Cleton Jansen, Anne Marie ^q   Van't Veer, Laura ⁿ   Benitez, Javier ^m   Casey, Graham ^l   Peterlin, Borut ^k   Olah, Edith ^j   Varley, Jenny ⁱ   Bignon, Yves Jean ^f   Scherneck, Siegfried ^e   Sigurdardottir, Valgerdur ^d   Lidereau, Rosette ^g   Eyfjord, Jorunn ^d   Beckmann, Matthias Wilhelm ^c   Winqvist, Robert ^b   Skovlund, Eva ^a   Børresen Dale, Anne Lise ^a   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d ICELANDIC CANCER SOCIETY   (Iceland)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f CENTRE JEAN PERRIN   (France)

^g CENTRE RENÉ HUGUENIN   (France)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^k Division of Medical Genetics   (Slovenia)

^l LERNER RESEARCH INSTITUTE   (United States)

^m Fund Jiménez Díaz ^*  (Spain)

ⁿ NETHERLANDS CANCER INSTITUTE   (Netherlands)

^o IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^p LUND UNIVERSITY   (Sweden)

^q LEIDEN UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME MAP; CLINICAL TRIAL; EUROPE; FEMALE; GENETIC RISK; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; SURVIVAL RATE; TRANSLOCATION, GENETIC;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0033030618     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199907)25:3<212::AID-GCC3>3.0.CO;2-G     Document Type: Article

References (45)

1. Arai Y, Hosoda F, Nakayama K, Ohki M. 1996. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3. Genomics 35:196-206.
2. Athma P, Rappaport R, Swift M. 1997. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134
3. Baffa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S, Croce CM. 1996. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 56:268-272.
4. Beckmann MW, Niederacher D, Schnürch H-G, Gusterson BA, Bender HG. 1997. Multistep carcinogenesis of breast cancer and tumor heterogeneity. J Mol Med 75:429-439.
5. Bethwaite PB, Koreth J, Herrington CS, McGee J O'D. 1995. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br J Cancer 71:814-818.
6. Bishop DT, Hopper J. 1997. A-T-tributable risk? Nat Genet 15:226.
7. Byrd PJ, Cooper PR, Stankovic T, Kullar HS, Watts GD, Robinson PJ, Taylor MR. 1996. A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies. Hum Mol Genet 5:1785-1791.
8. Børresen A-L, Andersen TI, Tretli S, Heiberg A, Møller P. 1990. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2:339-340.
9. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM. 1994. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54:6270-6274.
10. Chen X, Yang L, Udar N, Liang T, Uhrhammer N, Xu S, Bay JO, Wang Z, Dandakar S, Chiplunkar S, Klisak I, Telatar M, Yang H, Concannon P, Gatti RA. 1997. CAND3: a ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1. Mamm Genome 8:129-133.
11. Chen J, Giesler G, Lindblom P, Rubio C, Lindblom A. 1998. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58:1376-1379.
12. Claus EB, Risch NJ, Thompson WD. 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232-242.
13. Davis M, Hitchcock A, Foulkes WD, Campbell IG. 1996. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741-744.
14. Devilee P, van Schothorst EM, Bardoel AF, Bonsing B, Kuipers-Dijkshoorn N, James MR, Fleuren G, van der Mey AG, Cornelisse CJ. 1994. Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL. Genes Chromosomes Cancer 11:71-78.
15. Easton DF. 1994. Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:177-182.
16. Eeles RA, Stratton MR, Goldgar DE, Easton DF. 1994. The genetics of familial breast cancer and their practical implications. Eur J Cancer 30:1383-1390.
17. Fitzgerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307-310.
18. Funari B, Rhind N, Russell P. 1997. Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science 277:1495-1497.
19. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RCF, Steel CM, Porteous DJ, Smyth JF. 1996. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56:950-954.
20. Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V, Ingvarsson S. 1995. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 72:696-701.
21. Gustafson CE, Young J, Leggett B, Searle J, Chenevix-Trench G. 1994. Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumors. Br J Cancer 70:395-397.
22. Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA. 1994a. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 1q23.3. Cancer Res 54:4586-4589.
23. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA. 1994b. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
24. Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC. 1995. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res 55:2494-2496.
25. Hui ABY, Lo K-W, Leung S-F, Choi PHK, Fong Y, Lee JCK, Huang DP. 1996. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56:3225-3229.
26. Hutter R. 1987. World-wide agreement on the staging of cancer. Arch Surg 122:1235-1246.
27. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H, Birnbaum D. 1997. Loss of heterozygosity in human breast carcinomas in the ataxia-telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339-347.
28. Laake K, Ødegård Å, Andersen TI, Bukholm IK Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale A-L. 1997. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18:175-180.
29. Luo L, Lu FM, Hart S, Foroni L, Rabbani H, Hammarstrom L, Webster AD, Vorechovsky I. 1998. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. Cancer Res 58:2293-2297.
30. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WB, Croce CM. 1995. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55:3003-3007.
31. Pippard EC, Hall AJ, Barker DJP, Bridges BA. 1988. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2932.
32. Platzer M, Rotman G, Bauer D, Uziel T, Savitsky K, Bar-Shira A, Gilad S, Shiloh Y, Rosenthal A. 1997. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7:592-605.
33. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM. 1995. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 55:3988-3991.
34. Robertson G, Coleman A, Lugo TG. 1996. A malignant melanoma tumor suppressor on human chromosome 11. Cancer Res 56:4487-4492.
35. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501.
36. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y. 1990. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184-7189.
37. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman TS, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
38. Savitsky K, Ziv Y, Bar-Shira A, Gilad S, Tagle DA, Smith S, Uziel T, Sfez S, Nahmias J, Sartiel A, Eddy RL, Shows TB, Povey S, Collins FS, Shiloh Y, Rotman G. 1996. A human gene encoding a putative DEAD-box RNA helicase at 11q22-23. Genomics 33:199-206.
39. Stankovic T, Byrd PJ, Cooper PR, McConville CM, Munroe DJ, Riley JH, Watts GD, Ambrose H, McGuire G, Smith AD, Sutcliffe A, Mills T, Taylor AM. 1997. Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genes. Genomics 40:267-276.
40. Swift M, Reintnauer PJ, Morrell D, Chase CL. 1987. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294.
41. Swift M, Morrell D, Massey RB, Chase CL. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836.
42. Vanagaite L, James MR, Rotman G, Savitsky K, Bar-Shira A, Gilad S, Ziv Y, Uchenik V, Sartiel A, Collins FS, et al. 1995. A high-density microsatellite map of the ataxia-telangiectasia locus. Hum Genet 95:451-454.
43. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarström L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M. 1996a. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732.
44. Vorechovsky I, Luo L, Lindblom A, Negrini M, Webster D, Croce CM, Hammarström L. 1996b. ATM mutations in cancer families. Cancer Res 56:4130-4133.
45. Winqvist R, Hampton A, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, Cavenee WK. 1995. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55:2660-2664.